Vermont · 2025-2026 Regular Session · Bill
H 676: An act relating to maintaining patient access to animal-derived thyroid medications
Introduced Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 676 is a bill introduced in the Vermont House on January 14, 2026. According to its official title, it concerns: An act relating to maintaining patient access to animal-derived thyroid medications. Primary sponsor: Greg Burtt (Republican), Dave Bosch (Republican), Robert Hooper. Most recent recorded action (January 14, 2026): Read first time and referred to the Committee on Health Care.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Greg Burtt | Primary sponsor | Republican | House | Caledonia-Washington |
| Dave Bosch | Primary sponsor | Republican | House | Rutland-2 |
| Robert Hooper | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Read first time and referred to the Committee on Health Care